Skip to main content

Lack of body cameras on ICE agents fuels more uncertainty over fatal shootings

See what video shows about fatal ICE-involved shooting in Maine

(CNN) — After federal immigration agents fatally shot two US citizens this January, the then-secretary of the Department of Homeland Security pledged to “rapidly” deploy body cameras to officers nationally.

“As funding is available, the body camera program will be expanded nationwide,” Kristi Noem wrote on social media on February 2. “We will rapidly acquire and deploy body cameras to DHS law enforcement across the country.”

But over five months later, the distribution of those body-worn cameras is still ongoing – and notably hadn’t reached the officers involved in fatal shootings in Houston and in Maine this past week. Neither victim was the intended target of the immigrant enforcement operations, officials have said.

The lack of body cameras for these Immigration and Customs Enforcement agents raises questions as to the pace and status of that national effort. In the meantime, the lack of firsthand video from federal officers – combined with DHS’ recent history of false statements – has deepened skepticism of the government’s narrative in these fatal shootings.

“They’ve got tons of money. Why they don’t have body cams I think is a very fair question,” Sen. Angus King of Maine told CNN on Monday night. “That would resolve this kind of factual issue that we’re going to be trying to resolve over the next several weeks here in Maine.”

The shootings this week underscore the years-long push for body cameras, both from the public and the officers themselves. Spurred by the 2014 police shooting and ensuing unrest in Ferguson, Missouri, police forces across the country have adopted and mandated the use of body cameras, a move law enforcement experts say helps ensure safe and accountable policing.

“Law enforcement officers across the country tell me body cameras actually do them a service when it comes to controversial cases,” CNN senior correspondent and former FBI agent Josh Campbell said.

Federal agencies, however, have been slow to adopt such devices, and the Trump administration has reversed itself on whether they are needed.

Border czar Tom Homan on Tuesday said ICE has a timeline to distribute body cameras to agents, though he declined to share the timing of those plans and blamed a partial government shutdown earlier this year for the delay.

“The body cameras have been ordered. There’s a deployment schedule on the books, and right now they’re training to train, so officers in each field office can train their officers on the use of the body cam,” Homan told CNN’s Kaitlan Collins at the White House. “That was delayed by the shutdown.”

Agents were not wearing cameras

The use of body cameras has largely garnered bipartisan agreement, particularly amid aggressive confrontations between federal agents and members of the public over the past year.

After the deaths of Renee Good and Alex Pretti in Minneapolis this year, Noem pledged to expand the body camera program and deploy the equipment to officers nationwide. The fiscal year 2026 funding for DHS allocates $20 million for the “procurement, deployment and operations” of body cameras for agents and officers.

Noem was fired in March and replaced later that month by former Sen. Markwayne Mullin of Oklahoma. Despite the change in leadership, Homeland Security officials have repeatedly told lawmakers that body cameras would be distributed across the country.

DHS plans to purchase more than 5,000 body-worn cameras with the $20 million provided by Congress, according to a source.

“We’ve been told that body cameras would be widely distributed,” King told reporters Monday, citing a conversation with Mullin. “The secretary told me that they’re on order, that they have been distributed widely across the country but not everywhere.”

Each ICE arrest team plans to have an agent wearing a body camera as the federal agency works toward distributing the equipment to all agents, according to a Homeland Security spokesperson, marking another change put in place following two fatal shootings involving ICE agents this month.

The spokesperson said equipping all ICE agents with body cameras nationwide is a “top priority” for the department, casting blame on the government shutdown earlier this year for the delay in distributing them.

“Body cameras have been deployed to more than half the field offices with the remaining half expected to receive them in less than 60 days,” the spokesperson said Thursday.

Still, the agents involved in the fatal shooting of a Mexican national in Houston last week did not have body cameras, a Homeland Security spokesperson confirmed. DHS said in a statement the man rammed into a law enforcement vehicle and refused to follow several verbal commands before an ICE agent fired his weapon in self-defense.

Similarly, the immigration agents in Maine involved in the Monday shooting of a 26-year-old father from Colombia were also not equipped with body cameras, the Homeland Security spokesperson confirmed Tuesday. DHS said in a statement the man attempted to flee the scene, and an officer “fearing for public safety” opened fire.

ICE policy has remained the same — the use of body cameras can be beneficial during operations — but not all regions have received the equipment.

Feds slow to wear body cameras

While local police departments have taken to body cameras, the federal government has been slower to adopt the technology.

It took until 2021 for the first federal agents to use body cameras, and years further for its wider use. In December, for example, the US Marshals finally equipped their deputies with body cameras through an initiative that began six years earlier.

In 2022, the Biden administration issued an executive order, “Advancing Effective, Accountable Policing and Criminal Justice Practices To Enhance Public Trust and Public Safety,” which mandated the use of body cameras by federal law enforcement.

ICE implemented a policy in January 2024 requiring most officers to wear body cameras during “all aspects of ICE enforcement activities,” except for certain investigative activities. ICE had started to deploy the cameras at the end of Biden’s term.

President Donald Trump rescinded that directive in an executive order at the start of his second term in January 2025.

Federal immigration agents also have bristled at having their tactics recorded by FBI agents wearing body cameras, CNN has reported. During one heated exchange last year, immigration agents who did not want to be captured on body camera footage refused to invite FBI agents along for an arrest operation, one of the sources said.

The lack of body cameras on immigration agents has frustrated efforts at oversight, particularly in the judiciary. Last year, a federal judge in Chicago said she would require all federal agents who were part of Operation Midway Blitz with body cameras to have them on during encounters with immigration protesters.

“That’s the nice thing about body cameras is that they pick up events before the triggering event happens,” the judge said.

This story has been updated with additional information.

The-CNN-Wire
™ & © 2026 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved.

Transcript: Former FDA commissioner Dr. Scott Gottlieb on ‘Face the Nation with Margaret Brennan,’ July 26, 2026

▶ Watch Video: Former FDA head praises response to cyclospora outbreak, but says it's not "under control yet" The following is the transcript of an interview with U.S. Ambassador to the United Nations Mike Waltz that aired on "Face the Nation with Margaret Brennan" on July 26, 2026.MARGARET BRENNAN: We turn now to former FDA Commissioner Dr. Scott Gottlieb. He sits on the boards of Pfizer and UnitedHealth. Dr. Gottlieb, it's good to have you back. We've got cyclospora outbreaks in nine states. It is now one of the nation's largest foodborne illness outbreaks. HHS Secretary Kennedy says it's under control. Do you think it is? DR. SCOTT GOTTLIEB: I don't think it's under control yet, per se. I think that they've done a good job, FDA has, isolating this to central Mexico and some specific farms as well. It appears that a lot of these cases are emanating from farms in central Mexico, and there was probably some kind of event there. Remember, this particular parasite-the only known reservoir for it is human fecal matter, so probably sewage got onto those growing fields in central Mexico and contaminated those crops. Nobody's sure how yet. And so by isolating it to that region, a lot of restaurants, a lot of wholesalers, retailers have been able to cut off supplies from central Mexico, and I think that mitigates the risk. I don't think this is fully under control yet because we don't know for sure that that's the only growing region where this is coming from. But it does seem to be the case at this point. Some of the cases that are being reported right now probably are cases happening from other parts of the- the world and other parts of the country that are normal background cases that you see. There's probably increased reporting, but clearly the bulk of these cases appear to be coming from that central Mexican region. It's worth noting that Mexican authorities, public health authorities, deny that they're responsible for this.MARGARET BRENNAN: Well, I saw you recommended people buy heads of lettuce, not pre-chopped bags, buy locally, not from the grocery store. Why aren't we hearing more from the current FDA commissioner on that kind of advice?DR. SCOTT GOTTLIEB: Yeah, look, I think that there is some challenges with communications from the FDA. I think FDA has done a good job isolating this, and they were fast to do this. This is a hard pathogen to detect. There's no really good test for it, so you can't test for it in food. But there hasn't been as much communication from the agency as you might expect. There are things that consumers can do. You can buy a whole head of lettuce, like you said, and chop it up rather than buying bag lettuce. There's higher risk with bag lettuce. You can source locally. There haven't been known outbreaks from locally sourced produce. Prior to 2016, 2017, we never saw this particular species in U.S. sourced produce. It started to appear in California produce, but certainly in lower levels than what you see in Mexico and South America. There is a weather component here.MARGARET BRENNAN: There is, though, as you know, a public- public confidence crisis here when it comes to our health agencies. Our polling showed 47% of Americans do not have much confidence in the FDA to deal with the outbreak. That must hit hard as the former FDA commissioner. But it's also in part in the public space. They're looking not just at the personnel cuts, but like the Wall Street Journal is reporting that Taylor Farms, one of the companies that is- has been identified as- as selling some of the lettuce, at least that is in question. They contacted the White House to request a delay in announcing a recall, and the White House had the FDA join that call. That is not standard operating procedure, is it?DR. SCOTT GOTTLIEB: No, it's not, and it wasn't standard operating procedure when I was at FDA. I dealt with outbreaks in romaine lettuce and spinach as well, E. coli in spinach and romaine lettuce. I never heard from the White House on those things, other than to have discussions to inform them of what we were doing, so that they were properly briefed and could respond to questions that they were getting. So it's unusual. I don't think it really led to a significant delay in the ability of FDA to communicate in this case, based on that reporting, probably days, certainly not weeks. I think the breakdown here really was with CDC in identifying that initial cluster. By and large, we were dependent upon public health officials in Michigan to isolate that cluster. CDC really didn't seem to be as involved as the agency normally would be. Michigan public health officials led that response. Once they- once they isolated the cluster, however, the traceback to the farm and to the particular food source happened relatively fast. We had an outbreak of E. coli in romaine lettuce back in 2018. It took us many weeks to isolate that to a specific growing region. They were able to do that in a matter of, maybe days here, certainly weeks. So I think FDA worked pretty quickly to do it. MARGARET BRENNAN: I want to ask you about the CDC announcement that there are now more measles infections in 2026 than in the past 35 years. The American Academy of Pediatrics warns it's America's children that are going to pay the price for this. Ninety-three percent of this year's cases are among the unvaccinated, or the vaccination status is unknown. Should we, at any point, expect the Trump administration to lead a national campaign to get your kid vaccinated against measles, or did that die with MAHA? DR. SCOTT GOTTLIEB: Yeah, look, I think we need to accept that measles elimination is no longer the policy of this administration or certainly Secretary Kennedy, and I wouldn't expect any kind of concerted effort so long as he is in that position. This is his stated policy to, in some cases, discourage vaccination, but certainly not encourage it. And the children who aren't getting vaccinated right now are babies. Once they age into settings where they can contract that disease – kindergarten, preschool, daycare – you're going to see cases continue to rise in this country. It's not going to go down; it's going to continue to go up. Look at flu, for example. We had a record number of pediatric flu deaths last year, 298 pediatric flu deaths. We have almost 200 this year, and the secretary has said children don't need to get vaccinated for flu. So this is across the board; it's not just measles. These infections are very serious. There's a lot of long-term sequelae, even if you survive the infection.MARGARET BRENNAN: Let me quickly ask you. Supplement makers don't have to do what pharmaceutical companies do in terms of proving through clinical trials that products are safe. There's this push for this advisory board at the FDA to make, I guess, six peptides be added to a list of substances pharmacies can compound and produce. Is that wider access a good thing or a bad thing?DR. SCOTT GOTTLIEB: Well, I think it's a bad thing from the standpoint that there's not any proven benefits from these compounds that are in question. These are compounds being formulated by pharmacies. They're compounded products. They're peptides that people inject. There's risks associated with that, and there aren't any proven benefits. The most popular of these is the substance called PBC-157,* which people have ascribed a whole range of health benefits to. The only clinical study that the FDA was able to review was a 30-patient clinical study in a setting of ulcerative colitis, where they found no benefit. So there isn't clinical data associated with these, so I think there's risk with no- no demonstrated benefit that people are going to derive.MARGARET BRENNAN: Dr. Gottlieb, I've got to leave it there. Always good to talk to you. We'll be right back.EDITOR'S NOTE: This was in reference to the peptide BPC-157, not PBC-157.
Read Next Story